Asthma - Versorgungsleitlinien.de
Asthma - Versorgungsleitlinien.de
Asthma - Versorgungsleitlinien.de
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
NVL <strong>Asthma</strong>, 2. Auflage<br />
Langfassung<br />
Juli 2011, Version 1.3<br />
513. The Tobacco Use and Depen<strong>de</strong>nce Clinical Practice Gui<strong>de</strong>line Panel, Staff, and Consortium<br />
Representatives. A clinical practice gui<strong>de</strong>line for treating tobacco use and <strong>de</strong>pen<strong>de</strong>nce: A<br />
US Public Health Service report. JAMA 2000;283(24):3244-54.<br />
514. Lancaster T, Stead LF. Self-help interventions for smoking cessation. Cochrane Database Syst<br />
Rev 2005;(3):CD001118.<br />
515. Stead LF, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane<br />
Database Syst Rev 2006;3:CD002850.<br />
516. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane<br />
Database Syst Rev 2005;(2):CD001007.<br />
517. Gorin SS, Heck JE. Meta-analysis of the efficacy of tobacco counseling by health care provi<strong>de</strong>rs.<br />
Cancer Epi<strong>de</strong>miol Biomarkers Prev 2004;13(12):2012-22.<br />
518. Miller WR, Rollnick S. Motivational interviewing: Preparing people for change. New York:<br />
Guilford Pr.; 1991.<br />
519. White AR, Rampes H, Campbell JL. Acupuncture and related interventions for smoking<br />
cessation. Cochrane Database Syst Rev 2006;(1):CD000009.<br />
520. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking<br />
cessation. Cochrane Database Syst Rev 2004;(3):CD000146.<br />
521. Brunnhuber K, Cummings KM, Feit S, Sherman S, Woodcock J. Putting evi<strong>de</strong>nce into practice:<br />
Smoking cessation. 2007 [cited: 2008 Dez 02]. Available from:<br />
http://clinicalevi<strong>de</strong>nce.bmj.com/downloads/smoking-cessation.pdf<br />
522. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA, Jr., Enright<br />
PL, Kanner RE, O'Hara P. Effects of smoking intervention and the use of an inhaled<br />
anticholinergic bronchodilator on the rate of <strong>de</strong>cline of FEV1. The Lung Health Study. JAMA<br />
1994;272(19):1497-505.<br />
523. Murray RP, Connett JE, Rand CS, Pan W, Anthonisen NR. Persistence of the effect of the Lung<br />
Health Study (LHS) smoking intervention over eleven years. Prev Med 2002;35(4):314-9.<br />
524. Hughes JR, Stead LF, Lancaster T. Anti<strong>de</strong>pressants for smoking cessation. Cochrane Database<br />
Syst Rev 2007;(4):CD000031.<br />
525. Wu P, Wilson K, Dimoulas P, Mills EJ. Effectiveness of smoking cessation therapies: a<br />
systematic review and meta-analysis. BMC Public Health 2006;6:300.<br />
526. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation.<br />
Cochrane Database Syst Rev 2007;(1):CD006103.<br />
527. National Institute for Health and Clinical Excellence (NICE). Varenicline for smoking cessation.<br />
2007 [cited: 2008 Jan 31]. Available from:<br />
http://www.nice.org.uk/nicemedia/pdf/TA123Guidance.pdf<br />
528. U.S. Food and Drug Administration (FDA). Varenicline (marketed as Chantix) Information. 2008<br />
[cited: 2008 Okt 29]. Available from:<br />
http://www.fda.gov/c<strong>de</strong>r/drug/infopage/varenicline/<strong>de</strong>fault.htm<br />
Gilt nur für<br />
Erwachsene<br />
Gilt nur für<br />
Kin<strong>de</strong>r/Jugendliche<br />
Allgemeine<br />
Empfehlungen<br />
© 2009 237
Change language